The big story has been the deal with MedImmune, however, equally important have been updates on the collaboration with Roche.
Amanda Ellis from BioTechnology News has filed a story Phylogica captures AZ, preps Roche Candidate, dated August 19, 2010;
http://www.biotechnologynews.net/StoryView.asp?StoryID=1139066
Dr Paul Watt discusses the next step in the Roche collaboration which complements the news outlined in The CEO Transcript. We have a picture of an extremely exciting development. Essentially, Phylogica believes that it has come up with the goods and is ready to report back to Roche.
Its one thing to sign an agreement; its quite another to deliver upon the terms of the agreement. If Roche shares Watt's confidence then we have a large deal coming down the pipeline.
roche, the next step
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.5¢ | $29.56K | 278.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1274092 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 432957 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |